Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IdentiPHI was a healthcare information technology company that specialized in identity management and biometric authentication solutions. The company's primary mission was to secure access to Protected Health Information (PHI) and streamline clinical workflows through enterprise single sign-on (SSO) and multi-factor authentication. Its technology allowed healthcare providers to replace traditional passwords with biometric identifiers like fingerprints, enhancing both security and efficiency in hospital settings. IdentiPHI was acquired by Saflink Corporation in 2008, which subsequently adopted the IdentiPHI name before filing for bankruptcy in 2009.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IdentiPHI.